About AngioDynamics
AngioDynamics (NASDAQ:ANGO) focuses on developing innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease, and oncology. AngioDynamics is committed to improving patient outcomes by providing healthcare professionals with state-of-the-art products that support a wide range of medical procedures. Their portfolio includes a broad range of devices, including catheters, port systems, and microwave ablation systems, designed to make procedures more efficient and reduce recovery times. By continuously investing in research and development, AngioDynamics aims to advance its technologies and expand its product offerings to meet the evolving needs of the healthcare industry. Their objective is not only to lead in the markets they serve but also to provide solutions that deliver superior clinical results and economic value to healthcare providers and patients alike.
Snapshot
Operations
Products and/or services of AngioDynamics
- Oncology: Offers innovative, minimally invasive medical devices for cancer diagnosis and treatment, including the NanoKnife System for the surgical ablation of soft tissues.
- Vascular Interventions and Therapies: Provides a wide range of products, including thrombectomy systems, angiographic catheters, and port access needles, designed to improve patient outcomes in vascular interventions.
- Vascular Access: Focuses on developing technologies that facilitate the safe, efficient delivery of intravenous therapies, including PICC (Peripherally Inserted Central Catheters) and midline catheters.
- Venous Insufficiency: Offers solutions for the treatment of varicose veins and chronic venous insufficiency, such as the VenaCure EVLT system, a minimally invasive laser therapy.
- Fluid Management: Develops products for the efficient management and monitoring of fluid levels within the body during medical procedures, enhancing patient care.
- AngioVac System: A unique venous drainage system designed for the removal of unwanted intravascular material, offering a minimally invasive option for patients requiring venous intervention.
AngioDynamics executive team
- Mr. James C. ClemmerCEO, President & Director
- Mr. Stephen A. TrowbridgeExecutive VP & CFO
- Mr. Lawrence T. WeissSenior VP, Chief Legal Officer & Corporate Secretary
- Mr. Warren G. NighanSenior Vice President of Regulatory Affairs, Quality & Global Supply Chain
- Ms. Laura PiccininiSenior VP and GM of Cardiovascular & International
- Mr. Saleem M. CheeksVice President of Communications
- Mr. Benjamin H. DavisSenior Vice President of Business Development & Strategy
- Ms. Marna I. Bronfen-MooreSenior Vice President of Human Resources
- Mr. Chad T. CampbellSenior VP and GM of Oncology & Interventional Devices
- Ms. Kim L. SeaburySenior Vice President of Information Technology